Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get this delivered to your inbox, and ...
ImmunityBio has surged over 200% YTD, yet I see little fundamental justification for its current $10B enterprise value. Click here to read why IBRX is a Sell.
Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsByron Jeffers - VP, Treasurer & Head of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果